首页> 美国卫生研究院文献>The Journal of Clinical Investigation >Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.
【2h】

Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart. Regulation of NOS3 transcription in vitro and in vivo by cyclic adenosine monophosphate in rat cardiac myocytes.

机译:一氧化氮合酶(NOS3)和对心脏中肾上腺素能和胆碱能激动剂的收缩反应性。大鼠心肌细胞中环磷酸腺苷在体内和体外对NOS3转录的调节。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiac myocytes express the nitric oxide synthase isoform originally identified in constitutive nitric oxide synthase cells (NOS3), which mediates the attenuation by muscarinic cholinergic agonists of beta-adrenergic stimulation of L-type calcium current and contractility in these cells. However, calcium current and contractility in these cells. However, the reciprocal regulation of NOS3 activity in myocytes by agents that elevate cAMP has not been reported. In this study, we show that NOS3 and mRNA and protein levels in cardiac myocytes are reduced both in vitro after treatment with cAMP elevating drugs, and in vivo after 3 d of treatment with milrinone, a type III cAMP phosphodiesterase inhibitor. This effect on NOS3 activity by cAMP is cell type specific because treatment of cardiac microvascular endothelial cells in vitro or in vivo did not decrease NOS3 mRNA or protein in these cells. NOS3 downregulation in myocytes appeared to be at the level of transcription since there was no modification of NOS3 mRNA half-life by agents that increase intracellular cAMP. To determine the functional effects of NOS3 downregulation, we examined the contractile responsiveness of isolated electrically paced ventricular myocytes, isolated from animals that had been treated in vivo with milrinone, to the beta-adrenergic agonist isoproterenol and the muscarinic cholinergic agonist carbamylcholine. There was no difference in baseline contractile function in cells that had been pretreated with cAMP elevating agents compared to controls, but cells exposed to milrinone in vivo exhibited an accentuation in their contractile responsiveness to isoproterenol compared to controls and a loss of responsiveness to carbamylcholine. Downregulation of myocyte NOS3 by sustained elevation of cAMP may have important implications for the regulation of myocardial contractile state by the autonomic nervous system.
机译:心肌细胞表达最初在组成型一氧化氮合酶细胞(NOS3)中鉴定的一氧化氮合酶同工型,其介导毒蕈碱胆碱能激动剂对β-肾上腺素刺激L型钙电流和这些细胞的收缩力的衰减。但是,这些细胞的钙电流和收缩性。但是,尚未报道过通过升高cAMP的药物相互调节肌细胞中NOS3活性。在这项研究中,我们显示心肌细胞中的NOS3以及mRNA和蛋白质水平在用cAMP升高药物治疗后在体外,以及在用米力农(III型cAMP磷酸二酯酶抑制剂)治疗3天后在体内都降低了。 cAMP对NOS3活性的这种影响是特定细胞类型的,因为在体外或体内对心脏微血管内皮细胞的治疗不会降低这些细胞中的NOS3 mRNA或蛋白质。肌细胞中NOS3的下调似乎处于转录水平,因为没有增加细胞内cAMP的药物对NOS3 mRNA半衰期的改变。为了确定NOS3下调的功能效应,我们检查了分离的电起搏心室肌细胞(对从经过milrinone体内治疗的动物体内分离)对β-肾上腺素能激动剂异丙肾上腺素和毒蕈碱胆碱能激动剂氨甲酰胆碱的收缩反应性。与对照组相比,经cAMP增强剂预处理的细胞的基线收缩功能没有差异,但与对照组相比,在体内暴露于米力农的细胞对异丙肾上腺素的收缩反应性增强,并且对氨甲酰胆碱的响应性丧失。 cAMP持续升高下调心肌细胞NOS3可能对自主神经系统对心肌收缩状态的调节具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号